Remote buprenorphine-naloxone initiation as an essential service for people with chronic pain and opioid dependence during the COVID-19 pandemic: Case reports, clinical pathways, and implications for the future

Hance Clarkea Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Ontario, Canada;b Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada;c University of Toronto Centre for the Study of Pain, Toronto, Ontario, CanadaCorrespondence[email protected]
View further author information

Aliza Weinribb Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada;d Department of Psychology, York University, Toronto, Ontario, CanadaView further author information

Yuvaraj Kotteeswarana Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Ontario, Canada;b Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Toronto, Ontario, CanadaView further author information

Joel Katza Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Ontario, Canada;b Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada;c University of Toronto Centre for the Study of Pain, Toronto, Ontario, Canada;d Department of Psychology, York University, Toronto, Ontario, CanadaView further author information

Alvis Yue Department of Family Medicine, University of Calgary, Calgary, Alberta, Canada;f Opioid Deprescribing Program, Alberta Health Services, Calgary, Alberta, CanadaView further author information

Robert Tanguayf Opioid Deprescribing Program, Alberta Health Services, Calgary, Alberta, Canada;g Department of Psychiatry and Surgery, University of Calgary, Calgary, Alberta, Canada;h Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, CanadaView further author information

Remote buprenorphine-naloxone initiation as an essential service for people with chronic pain and opioid dependence during the COVID-19 pandemic: Case reports, clinical pathways, and implications for the future

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Remote buprenorphine-naloxone initiation as an essential service for people with chronic pain and opioid dependence during the COVID-19 pandemic: Case reports, clinical pathways, and implications for the future

Figures & data

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date